DrugFeb 1, 2023
SODIUM CHLORIDE 0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag recall — FDA D-0177-2023
CGMP Deviations: potential for trace amounts of product carryover.
Class IIFDA: TerminatedNephron Sc Inc.
Recall history in this database
Classification mix: Class II: 3.
DrugFeb 1, 2023
Sterile Water for Injection, USP, For Drug Diluent Use Only, 5 mL Single-Dose Vial recall — FDA D-0178-2023
CGMP Deviations: potential for trace amounts of product carryover.
Class IIFDA: TerminatedNephron Sc Inc.
DrugFeb 1, 2023
S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile recall — FDA D-0176-2023
Short Fill
Class IIFDA: TerminatedNephron Sc Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Nephron Sc Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.